Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.

Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ.

Eur J Cancer. 2013 Mar;49(4):938-45. doi: 10.1016/j.ejca.2012.09.030. Epub 2012 Oct 15.

PMID:
23079475
2.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

3.
4.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

5.

Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.

Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.

Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):5-26. Review.

PMID:
12852480
7.

Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.

Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC.

J Natl Cancer Inst. 2003 Dec 3;95(23):1784-91. Review.

9.

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.

Wilson JC, Anderson LA, Murray LJ, Hughes CM.

Cancer Causes Control. 2011 May;22(5):803-10. doi: 10.1007/s10552-011-9751-6. Epub 2011 Mar 17. Review.

PMID:
21409528
10.

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.

Liu Y, Chen JQ, Xie L, Wang J, Li T, He Y, Gao Y, Qin X, Li S.

BMC Med. 2014 Mar 28;12:55. doi: 10.1186/1741-7015-12-55. Review.

11.

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG.

Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15. Review.

PMID:
20844293
12.

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.

Mahmud S, Franco E, Aprikian A.

Br J Cancer. 2004 Jan 12;90(1):93-9. Review.

13.

Clinical evidence of the relationship between aspirin and breast cancer risk (review).

Jacobo-Herrera NJ, Pérez-Plasencia C, Camacho-Zavala E, González GF, Urrutia EL, García-Castillo V, Zentella-Dehesa A.

Oncol Rep. 2014 Aug;32(2):451. doi: 10.3892/or.2014.3270. Epub 2014 Jun 13. Review.

PMID:
24927467
14.

Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N.

Cancer Causes Control. 2012 Nov;23(11):1839-52. doi: 10.1007/s10552-012-0063-2. Epub 2012 Sep 13. Review.

15.

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.

Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Int J Cancer. 2013 Mar 1;132(5):1146-55. doi: 10.1002/ijc.27717. Epub 2012 Jul 27. Review.

16.

High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis.

Cui XJ, He Q, Zhang JM, Fan HJ, Wen ZF, Qin YR.

Pancreas. 2014 Jan;43(1):135-40. doi: 10.1097/MPA.0b013e3182a8d41f. Review.

PMID:
24263109
17.

Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.

Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK.

Gynecol Oncol. 2016 Feb;140(2):352-8. doi: 10.1016/j.ygyno.2015.12.009. Epub 2015 Dec 14. Review.

PMID:
26701413
18.

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

Samii A, Etminan M, Wiens MO, Jafari S.

Drugs Aging. 2009;26(9):769-79. doi: 10.2165/11316780-000000000-00000. Review.

PMID:
19728750
19.

Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn.

Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA.

Pediatrics. 2013 Jan;131(1):79-87. doi: 10.1542/peds.2012-0496. Epub 2012 Dec 3. Review.

20.

Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.

Stepensky D, Rimon G.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):41-52. doi: 10.1517/17425255.2014.971010. Epub 2014 Oct 13. Review.

PMID:
25307725
Items per page

Supplemental Content

Write to the Help Desk